Inhibition of tumor growth and metastasis by depletion of vesicular sorting protein Hrs:: Its regulatory role on E-cadherin and β-catenin

被引:65
作者
Toyoshima, Masafumi
Tanaka, Nobuyuki
Aoki, Jun
Tanaka, Yoshinori
Murata, Kazuko
Kyuuma, Masanao
Kobayashi, Hideyuki
Ishii, Naoto
Yaegashi, Nobuo
Sugamura, Kazuo
机构
[1] Tohoku Univ, Grad Sch Med, Dept Microbiol & Immunol, Sendai, Miyagi 9808575, Japan
[2] Tohoku Univ, Grad Sch Med, Dept Obstet & Gynecol, Sendai, Miyagi 9808575, Japan
关键词
D O I
10.1158/0008-5472.CAN-06-2756
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Abnormally high signals from receptor tyrosine kinases (RTK) are associated with carcinogenesis, and impaired deactivation of RTKs may also be a mechanism in cancer. Hepatocyte growth factor-regulated tyrosine kinase substrate (Hrs) is one of the master regulators that sort activated receptors toward lysosomes and shut down their signals. Hrs contains a ubiquitin-interacting motif and is involved in the endosomal sorting of monoubiquitinated membrane proteins, such as growth factor receptor and E-cadherin. Here, we investigated the role of Hrs in determining the malignancy of cancer cells and discovered that the targeted disruption of Hrs by small interfering RNA effectively attenuated the proliferation, anchorage-independent growth, tumorigenesis, and metastatic potential of HeLa cells in vitro and in vivo. The restoration of Hrs expression increased cell proliferation and anchorage-independent growth in a mouse embryonic fibroblast line established from a Hrs knockout mouse. Further analysis revealed that Hrs depletion was associated with the up-regulation of E-cadherin and reduced beta-catenin signaling. The aberrant accumulation of E-cadherin most likely resulted from impaired E-cadherin degradation in lysosomes. These results suggest that Hrs may play a critical role in determining the malignancy of cancer cells by regulating the degradation of F-cadherin.
引用
收藏
页码:5162 / 5171
页数:10
相关论文
共 50 条
[1]   Met/hepatocyte growth factor receptor ubiquitination suppresses transformation and is required for Hrs phosphorylation [J].
Abella, JV ;
Peschard, P ;
Naujokas, MA ;
Lin, T ;
Saucier, C ;
Urbé, S ;
Park, M .
MOLECULAR AND CELLULAR BIOLOGY, 2005, 25 (21) :9632-9645
[2]   Hrs is associated with STAM, a signal-transducing adaptor molecule - Its suppressive effect on cytokine-induced cell growth [J].
Asao, H ;
Sasaki, Y ;
Arita, T ;
Tanaka, N ;
Endo, K ;
Kasai, H ;
Takeshita, T ;
Endo, Y ;
Fujita, T ;
Sugamura, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (52) :32785-32791
[3]   Defective downregulation of receptor tyrosine kinases in cancer [J].
Bache, KG ;
Slagsvold, T ;
Stenmark, H .
EMBO JOURNAL, 2004, 23 (14) :2707-2712
[4]   Hrs regulates multivesicular body formation via ESCRT recruitment to endosomes [J].
Bache, KG ;
Brech, A ;
Mehlum, A ;
Stenmark, H .
JOURNAL OF CELL BIOLOGY, 2003, 162 (03) :435-442
[5]   STAM and Hrs are subunits of a multivalent ubiquitin-binding complex on early endosomes [J].
Bache, KG ;
Raiborg, C ;
Mehlum, A ;
Stenmark, H .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (14) :12513-12521
[6]   The ins and outs of E-cadherin trafficking [J].
Bryant, DM ;
Stow, JL .
TRENDS IN CELL BIOLOGY, 2004, 14 (08) :427-434
[7]   Autoregulation of E-cadherin expression by cadherin-cadherin interactions:: the roles of β-catenin signaling, Slug, and MAPK [J].
Conacci-Sorrell, M ;
Simcha, I ;
Ben-Yedidia, T ;
Blechman, J ;
Savagner, P ;
Ben-Ze'ev, A .
JOURNAL OF CELL BIOLOGY, 2003, 163 (04) :847-857
[8]   Disassembling adherens junctions: breaking up is hard to do [J].
D'Souza-Schorey, C .
TRENDS IN CELL BIOLOGY, 2005, 15 (01) :19-26
[9]  
da Rocha Anderson Alves, 2006, Pituitary, V9, P83
[10]   β-Catenin and TGFβ signalling cooperate to maintain a mesenchymal phenotype after FosER-induced epithelial to mesenchymal transition [J].
Eger, A ;
Stockinger, A ;
Park, J ;
Langkopf, E ;
Mikula, M ;
Gotzmann, J ;
Mikulits, W ;
Beug, H ;
Foisner, R .
ONCOGENE, 2004, 23 (15) :2672-2680